Community Dining, Walking, and Glucose in Older Adults (NCT07695675) | Clinical Trial Compass
RecruitingNot Applicable
Community Dining, Walking, and Glucose in Older Adults
China15 participantsStarted 2026-08-01
Plain-language summary
This study will examine whether eating lunch and dinner at a subsidized community dining site affects postmeal walking and blood glucose patterns in older adults. Participants will be community-dwelling adults aged 60 to 79 years who are eligible for a local elderly meal subsidy and have prediabetes or elevated blood glucose risk.
Each participant will complete two 6-day meal conditions in random order. In one condition, participants will eat lunch and dinner at home. In the other condition, participants will eat lunch and dinner at a subsidized community dining site. Participants will wear a continuous glucose monitor and an activity tracker so the study team can measure postmeal glucose levels, daily glucose patterns, and steps after meals.
The study will compare community dining with home eating to determine whether community dining increases postmeal walking, improves postmeal glucose responses, and affects loneliness and meal experience.
Who can participate
Age range
60 Years – 79 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Community-dwelling adults aged 60 to 79 years
* Eligible for the local elderly meal subsidy
* Prediabetes or elevated glycemic risk, defined as HbA1c 5.7% to 6.4% or fasting plasma glucose 100 to 125 mg/dL
* Able to consume meals orally
* Able to walk independently without a walking aid
* Able to attend the community dining site safely
* Able and willing to wear a continuous glucose monitor and activity tracker
* Able and willing to follow the home-meal plan and study procedures
* Able to provide written informed consent
Exclusion Criteria:
* HbA1c ≥6.5% or fasting plasma glucose ≥126 mg/dL
* Diagnosed diabetes
* Use of insulin or glucose-lowering medication
* Severe cognitive impairment
* Acute illness or recent hospitalization
* Severe gastrointestinal disease affecting usual food intake or gastric emptying
* Severe renal, hepatic, cardiovascular, or neurologic disease that would make participation unsafe
* Skin conditions preventing continuous glucose monitor use
* Food allergy or dietary restrictions incompatible with the standardized meal plan
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Meal-Level 0- to 90-Minute Postprandial Glucose Incremental Area Under the Curve
Timeframe: Study Days 2-13; fixed premeal baseline window through 90 minutes after completion of each lunch and dinner during the 12-day randomized meal-condition period.